Naloxone for the Treatment of Opioid-Induced Pruritus
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to improve how we treat itching, a common side effect associated
with the use of morphine pain medication. Itching is a problem experienced by up to 30% of
the children treated with pain medications in the morphine family.
Despite studies demonstrating the effectiveness of using naloxone to treat itchiness in
adults receiving morphine pain medications, there are not many studies in children. This
study is designed to study how well naloxone works for treatment of itching in children